罗氏计划将新乳腺癌药片命名为 Wilserdly
Roche plans to call its new breast-cancer pill Wilserdly, and has registered the name in multiple jurisdictions ahead of the potential approval of a d...
AI 导读
罗氏计划将其新乳腺癌药片命名为 Wilserdly，并已在多个司法管辖区注册该名称。此举在潜在获批之前进行，罗氏希望该药能在这种疾病的新型疗法中占据主导地位。